Related Experiment Video
Updated: Mar 24, 2026

High-throughput Screening for Small-molecule Modulators of Inward Rectifier Potassium Channels
Published on: January 27, 2013
Isoindolinone compounds active as Kv1.5 blockers identified using a multicomponent reaction approach.
Johan Kajanus1, Ingemar Jacobson1, Annika Åstrand2
1Cardiovascular & Metabolic Diseases, Innovative Medicines and Early Development Biotech Unit, AstraZeneca, Pepparedsleden 1, Mölndal, SE-431 83, Sweden.
Researchers developed novel isoindolinone compounds targeting the Kv1.5 ion channel. Modifications yielded metabolically stable molecules with favorable in vivo pharmacokinetics and low intrinsic clearance.
Area of Science:
- Medicinal Chemistry
- Pharmacology
- Ion Channel Modulation
Background:
- Kv1.5 ion channels play a crucial role in cardiac function.
- Developing selective modulators for Kv1.5 is important for treating cardiac arrhythmias.
- Isoindolinone scaffolds offer a promising structural basis for drug discovery.
Purpose of the Study:
- To synthesize and characterize novel isoindolinone derivatives.
- To evaluate the in vitro potency and in vivo pharmacokinetic properties of these compounds.
- To optimize compounds for metabolic stability and low intrinsic clearance.
Main Methods:
- Multi-component Ugi reactions for initial scaffold synthesis.
- Suzuki and Diels-Alder reactions for structural diversification.
- In vitro assays to determine Kv1.5 channel potency.
- In vivo pharmacokinetic studies to assess metabolic stability and clearance.
Main Results:
- A series of isoindolinone compounds demonstrated significant in vitro potency against the Kv1.5 ion channel.
- Modification of side chains on the isoindolinone core led to compounds with improved metabolic stability.
- Achieved low microsomal intrinsic clearance (CLint) despite relatively high lipophilicity (logD).
- Efficient synthesis using Ugi, Suzuki, and Diels-Alder reactions yielded diverse compounds rapidly.
Conclusions:
- Isoindolinone derivatives are effective modulators of the Kv1.5 ion channel.
- Strategic modification of the isoindolinone scaffold can yield compounds with desirable pharmacokinetic properties.
- This approach provides a viable route for developing metabolically stable Kv1.5 inhibitors.
Related Concept Videos
Antiarrhythmic Drugs: Class III Agents as Potassium Channel Blockers
Antiarrhythmic Drugs: Class I Agents as Sodium Channel Blockers
Class 1A Antiarrhythmic Drugs: These drugs work by moderately blocking sodium channels,...
Voltage-gated Ion Channels
Generally, all voltage-gated ion channels have a 'voltage-sensing domain' that spans the lipid bilayer. The charged residues in the sensor move in response to the membrane potential changes that open the channel allowing ions movement. There are several types of...
Voltage-gated Ion Channels
Depolarizing Blockers: Mechanism of Action
Succinylcholine is the most commonly used depolarizing blocker. Chemically, it constitutes two molecules of acetylcholine joined together by an acetate methyl group. They act on the receptors in the same way as acetylcholine. Because...
Antiepileptic Drugs: Potassium Channel Activators
Ezogabine has gained approval as an adjunctive treatment...

